Friday, April 04, 2025 8:23:27 PM
I think you underestimate the resolve. I have yet to hear a good answer to the question - if tariffs are so self-defeating as is claimed, then why do many, many other countries impose them on us? There are also clips of Sanders, Pelosi, and Obama from years back pushing for tariffs and/or reciprocal trade practices between nations.
As tariffs/trade policy relates to Elite, we manufacture domestically anyway. If tariffs go into effect on foreign API, then I would expect that to hit most if not all of the other generic manufacturers also. I think Nasrat mentioned this in the CC. So should be impacting most or all of them the same - generics could go up in price but they'd still be drastically below brand. We've already been discussing the added potential for Elite to strike a deal to manufacture a branded drug for other bigger pharmas if they need to start producing domestically.
Interestingly, which country dropped all remaining tariffs on us? Israel. What do we have launching there soon?
https://www.reuters.com/world/middle-east/israel-finmin-seeks-immediate-end-remaining-tariffs-us-imports-2025-04-01/
https://www.newsfilecorp.com/release/226314/Elite-Pharmaceuticals-Generic-AdderallR-Receives-Marketing-Approval-from-the-Israeli-Ministry-of-Health
I agree that we will be just fine. See you in Vegas!
As tariffs/trade policy relates to Elite, we manufacture domestically anyway. If tariffs go into effect on foreign API, then I would expect that to hit most if not all of the other generic manufacturers also. I think Nasrat mentioned this in the CC. So should be impacting most or all of them the same - generics could go up in price but they'd still be drastically below brand. We've already been discussing the added potential for Elite to strike a deal to manufacture a branded drug for other bigger pharmas if they need to start producing domestically.
Interestingly, which country dropped all remaining tariffs on us? Israel. What do we have launching there soon?
https://www.reuters.com/world/middle-east/israel-finmin-seeks-immediate-end-remaining-tariffs-us-imports-2025-04-01/
https://www.newsfilecorp.com/release/226314/Elite-Pharmaceuticals-Generic-AdderallR-Receives-Marketing-Approval-from-the-Israeli-Ministry-of-Health
I agree that we will be just fine. See you in Vegas!
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
